You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

entinostat

Showing 1 - 25 of 60
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

Metastatic Cancer, Renal Cancer Trial in Indianapolis, Columbus, Philadelphia (Atezolizumab, Bevacizumab, Entinostat)

Suspended
  • Metastatic Cancer
  • Renal Cancer
  • Indianapolis, Indiana
  • +3 more
Oct 29, 2022

Cancer, Solid Tumor, Metastatic Checkpoint Refractory HPV Associated Malignancies Trial run by the National Cancer Institute

Recruiting
  • Cancer
  • +3 more
  • Bintrafusp Alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 11, 2022

CNS Tumor, Solid Tumor Trial in Worldwide (Nivolumab and Entinostat)

Recruiting
  • CNS Tumor
  • Solid Tumor
  • Nivolumab and Entinostat
  • Randwick, New South Wales, Australia
  • +13 more
Nov 8, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-negative Breast Cancer
  • +6 more
  • entinostat
  • +3 more
  • Baltimore, Maryland
    University of Maryland Baltimore
Apr 29, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Placebo)

Completed
  • Neoplasms
  • +14 more
  • Entinostat
  • Placebo
  • San Antonio, Texas
    The START Center for Cancer Care
Apr 21, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

Renal Cell Carcinoma Trial in United States (Entinostat, Interleukin-2)

Active, not recruiting
  • Renal Cell Carcinoma
  • Los Angeles, California
  • +4 more
Feb 14, 2022

Renal Cell Carcinoma Trial in Washington, Indianapolis (Entinostat, Nivolumab, Ipilimumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Entinostat
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jan 10, 2022

Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

Completed
Has Results
  • Brain Stem Neoplasm
  • +9 more
  • Entinostat
  • +2 more
  • Birmingham, Alabama
  • +20 more
Jan 6, 2023

Extensive Stage Lung Small Cell Carcinoma, Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in United States

Active, not recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +3 more
  • New York, New York
  • +4 more
Jul 16, 2022

Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Denver, Sarasota, Nashville (entinostat, exemestane)

Completed
  • Breast Cancer
  • Estrogen Receptor Positive Breast Cancer
  • Denver, Colorado
  • +2 more
Dec 14, 2021

Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)

Active, not recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Entinostat
  • +4 more
  • Duarte, California
  • +4 more
Jul 16, 2022

Neuroendocrine Tumors Trial in New York (Entinostat)

Recruiting
  • Neuroendocrine Tumors
  • Entinostat
  • New York, New York
    Columbia University Medical Center
Oct 6, 2021

Breast Cancer, Triple Negative Breast Cancer, HER2+ Breast Cancer Trial run by the NCI (Brachyury-TRICOM, Entinostat, M7824)

Terminated
Has Results
  • Breast Cancer
  • +4 more
  • Brachyury-TRICOM
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2021

Lung Cancer, Non Small Cell Lung Cancer (NSCLC), Breast Cancer Trial in Sarasota, Oklahoma City, Nashville (entinostat,

Completed
  • Lung Cancer
  • +3 more
  • entinostat
  • +2 more
  • Sarasota, Florida
  • +2 more
Nov 11, 2021

Bladder Cancer Trial in Chapel Hill, Philadelphia (Pembrolizumab, Entinostat)

Recruiting
  • Bladder Cancer
  • Chapel Hill, North Carolina
  • +1 more
Oct 10, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)

Completed
  • Neoplasms
  • +13 more
  • San Antonio, Texas
    The START Center for Cancer Care
Jan 24, 2022

Prostate Adenocarcinoma Trial in Washington (Entinostat, Enzalutamide)

Terminated
  • Prostate Adenocarcinoma
  • Washington, District of Columbia
    George Washington University - Medical Faculty Associates
Jul 26, 2021

Breast Cancer Trial in Chikusa-ku, Chuo-ku (KHK2375, Exemestane)

Completed
  • Breast Cancer
  • Chikusa-ku, Aichi, Japan
  • +2 more
Jun 15, 2022

Advanced Breast Cancer Trial in Beijing (Entinostat, Placebo, Exemestane)

Active, not recruiting
  • Advanced Breast Cancer
  • Entinostat
  • +2 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy Medical Sciences
Jul 7, 2021

Breast Cancer Trial in Georgia, United States (entinostat, atezolizumab, Placebo)

Completed
  • Breast Cancer
  • entinostat
  • +2 more
  • Birmingham, Alabama
  • +28 more
May 9, 2022

Melanoma Trial in Chapel Hill (Entinostat, Pembrolizumab)

Recruiting
  • Melanoma
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
May 8, 2021

Non-Small-Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung Trial in United States (Entinostat, Placebo, Erlotinib)

Completed
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Carcinoma, Non-Small Cell Lung
  • Entinostat
  • +2 more
  • Tucson, Arizona
  • +29 more
Aug 18, 2022